[摘要]钠-葡萄糖协同转运蛋白-2抑制剂通过减少人体肾脏对葡萄糖的重吸收，增加尿糖的排泄，达到降低血液中葡萄糖水平的目的，从而成为治疗2型糖尿病的新途径。近年来，SGLT-2抑制剂类药物也不断的问世，给2型糖尿病患者的治疗带来了新的希望。

    [关键词] SGLT-2；SGLT-2抑制剂；2型糖尿病；尿糖排泄

    [中图分类号] R587.1 [文献标识码] A [文章编号] 2095-0616(2015)01-63-03

    [Abstract] Blood glucose levels lowered by sodium-glucose cotransporter 2 (SGLT-2) inhibitor that could reduced reabsorption of glucose by human kidney， increased urine glucose excretion， which was a new way to treat diabetes type 2. In recent years ......